BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28
• 29
• 30

• Press Releases

  Eikon Therapeutics Presents Data from PARP1-Selective and WRN Helicase Programs at the European Society for Medical Oncology Congress

  October 25, 2026

   · 

  16 min read
• Press Releases

  Precede Biosciences Presents ESMO 2026 Data Revealing Biology Associated with Response and Resistance to PSMA-Directed Radioligand Therapy in Advanced Prostate Cancer

  October 25, 2026

   · 

  3 min read
• Press Releases

  Celcuity Presents Updated Data from a Phase 1b/2 Study Evaluating Gedatolisib Plus Darolutamide in Men with Metastatic Castration-Resistant Prostate Cancer at the ESMO Congress 2026

  October 25, 2026

   · 

  7 min read
• Press Releases

  Bolt Biotherapeutics Announces Acquisition of Prana Therapies and $120 Million Concurrent Private Placement to Advance PRA-216 in Multiple High-Value Inflammatory Indications

  October 25, 2026

   · 

  14 min read
• Press Releases

  Elicio Therapeutics Presents Late-Breaking Phase 2 AMPLIFY-7P Results at ESMO Congress 2026 and Announces Simultaneous Publication in Nature Medicine

  October 25, 2026

   · 

  11 min read
• Press Releases

  Florida Cancer Specialists & Research Institute Drug Development Research Featured at ESMO Congress 2026

  October 25, 2026

   · 

  4 min read
• Press Releases

  Abbott presents new ESMO data showing 30-percent absolute improvement in sensitivity with the whole-genome sequencing Oncodetect® test in colorectal cancer

  October 25, 2026

   · 

  5 min read
• Press Releases

  Convergent Therapeutics to Present Phase 2 Results Demonstrating Potent Anti-Tumor Activity of CONV01-α in Lu-PSMA-Naïve Prostate Cancer at ESMO Congress 2026

  October 25, 2026

   · 

  5 min read
• Press Releases

  Faeth Presents Updated Preclinical Data at ESMO, including First-Ever Head-to-Head Characterization of PIKTOR against Gedatolisib

  October 25, 2026

   · 

  8 min read
• Press Releases

  Pathos AI Secures $237 Million in Series E Financing to Scale Agentic AI Drug Development Platform and Advance Oncology Pipeline

  October 25, 2026

   · 

  2 min read